Image

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Study on Investigational Medication for Advanced Solid Tumors

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced solid tumors. It focuses on assessing the safety and tolerability of an investigational medication in individuals with these conditions.

The study evaluates how the investigational medication affects the body, including its pharmacokinetics and anti-tumor activity.

  • Who can participate: Adults with advanced solid tumors may join. Participants should have a life expectancy of more than 3 months and meet specific health criteria.
  • Study details: Participants will receive an investigational medication to evaluate its effects. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
Print
Study details
    Head and Neck Squamous Cell Carcinoma (HNSCC)
    Pancreatic Adenocarcinoma
    Non-small Cell Lung Cancer (NSCLC)
    Platinum-resistant High-grade Epithelial Ovarian
    Primary Peritoneal
    or Fallopian Tube Cancers (HGSOC)
    Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma
    Triple Negative Breast Cancer (TNBC)

NCT05985655

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

22 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.